LYL1 gene amplification predicts poor survival of patients with uterine corpus endometrial carcinoma: analysis of the Cancer genome atlas data.

BMC Cancer · 2018 · PMC5930686 · PMID 29716549

Europe PMC DOI

hedged sentence

0.0630

closest p · 1.3× alpha

0.0630

boldest claim

The sentences

showed a trendP = 0.063so close (0.05 < p ≤ 0.1)

However, results of multivariate analysis showed a trend towards worse PFS in the patients with LYL1 gene amplification (adjusted HR, 4.093; 95% CI, 0.926–18.012; P = 0.063) (Table 3 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.